- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05272267
Transforming ED Throughput With AI-Driven Clinical Decision Support System (TEDAI)
July 28, 2023 updated by: National Taiwan University Hospital
Transforming ED Throughput With AI-Driven Clinical Decision Support System (TEDAI): The Impact on the Delivery of Care and Patient Experience
The aims of this study is to integrate real-time data flow infrastructure between hospital information system and AI models and to conduct a cluster randomized crossover trial to evaluate the efficacy of the AI models in improving patient flow and relieving ED crowding.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
4016
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan
- National Taiwan University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- ED patients aged 20 years or older
- Patients were treated by the recruited 16 ED attendings.
Exclusion Criteria:
- Patients aged less than 20 years.
- Patients were not treated by the recruited 16 ED attendings.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: AI-assisted
AI-assisted models providing diagnosis and prognostic information
|
AI-assisted models providing diagnosis and prognostic information in the ED, including triage, ICD coding, chest x ray alerts, critical event alerts, readmission prediction, and post-cardiac arrest prognostication.
|
|
Placebo Comparator: Usual care
usual care without AI-assisted models providing diagnosis and prognostic information
|
Critical treatment of the emergency room
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
ED length of stay
Time Frame: From ED arrival to 3 days after ED discharge. For hospitalized patients with cardiac arrest, the outcome ascertainment continues until hospital discharge.
|
From ED arrival to 3 days after ED discharge. For hospitalized patients with cardiac arrest, the outcome ascertainment continues until hospital discharge.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Dr. Huang, National Taiwan University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 30, 2022
Primary Completion (Actual)
December 31, 2022
Study Completion (Actual)
April 27, 2023
Study Registration Dates
First Submitted
February 28, 2022
First Submitted That Met QC Criteria
February 28, 2022
First Posted (Actual)
March 9, 2022
Study Record Updates
Last Update Posted (Actual)
August 1, 2023
Last Update Submitted That Met QC Criteria
July 28, 2023
Last Verified
July 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202108090RINC
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Care
-
Lisbon Academic Medical Center - Centro Académico...Centro Hospitalar de Vila Nova de Gaia/Espinho; Centro Hospitalar Lisboa Ocidental and other collaboratorsRecruitingCritical Illness | Critical Care | Critical Care, Intensive Care | Critical Care Medicine | Recovery OutcomesPortugal
-
Radiometer Medical ApSTerminated
-
Potrero MedicalCompletedCritical Care, Intensive Care
-
Davy van de SandeRecruitingCritical Care | Intensive Care MedicineNetherlands
-
Hospital Israelita Albert EinsteinActive, not recruitingCritical Care | Intensive Care UnitBrazil
-
Ruijin HospitalNot yet recruiting
-
University College, LondonCompleted
-
Hospital do CoracaoD'Or Institute for Research and Education; Sociedade Hospital SamaritanoCompleted
-
University Hospital, ToursRecruitingCritical Care, Intensive CareFrance
-
Hospital Israelita Albert EinsteinMinistry of Health, BrazilCompletedTelemedicine | Critical Care | Intensive Care UnitsBrazil
Clinical Trials on AI-assisted models providing diagnosis and prognostic information
-
Renmin Hospital of Wuhan UniversityShandong University; Shengjing Hospital; Guizhou Provincial People's Hospital; Air... and other collaboratorsRecruitingColorectal Adenoma | Artificial Intelligence (AI)China
-
First Affiliated Hospital of Guangxi Medical UniversityNot yet recruitingKidney Calculi | Urinary Bladder Neoplasms | Prostatic HyperplasiaChina, Vietnam
-
Tsinghua UniversityShanghai Sixth People's Hospital, Shanghai Jiao Tong University School of... and other collaboratorsActive, not recruitingCoronary Heart DiseaseChina
-
Liverpool School of Tropical MedicineCentre for Control of Chronic Disease (CCCD),icddr,b; Comité National d'Ethique... and other collaboratorsNot yet recruitingTB - Tuberculosis
-
Liverpool School of Tropical MedicineNot yet recruitingTB - Tuberculosis
-
NRG OncologyNational Cancer Institute (NCI)RecruitingClinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage I Esophageal Adenocarcinoma AJCC v8 | Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8 | Clinical Stage II Esophageal Adenocarcinoma AJCC v8 | Clinical Stage II Esophageal Squamous Cell Carcinoma... and other conditionsUnited States